chr6-32042485-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_001365276.2(TNXB):āc.12180C>Gā(p.Cys4060Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 20)
Exomes š: 0.000018 ( 1 hom. )
Failed GnomAD Quality Control
Consequence
TNXB
NM_001365276.2 missense
NM_001365276.2 missense
Scores
6
5
7
Clinical Significance
Conservation
PhyloP100: -0.883
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.84
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNXB | NM_001365276.2 | c.12180C>G | p.Cys4060Trp | missense_variant | 40/44 | ENST00000644971.2 | NP_001352205.1 | |
TNXB | NM_019105.8 | c.12174C>G | p.Cys4058Trp | missense_variant | 40/44 | NP_061978.6 | ||
TNXB | NM_032470.4 | c.1467C>G | p.Cys489Trp | missense_variant | 9/13 | NP_115859.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNXB | ENST00000644971.2 | c.12180C>G | p.Cys4060Trp | missense_variant | 40/44 | NM_001365276.2 | ENSP00000496448 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151752Hom.: 0 Cov.: 20
GnomAD3 genomes
AF:
AC:
5
AN:
151752
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250654Hom.: 1 AF XY: 0.0000295 AC XY: 4AN XY: 135660
GnomAD3 exomes
AF:
AC:
5
AN:
250654
Hom.:
AF XY:
AC XY:
4
AN XY:
135660
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000185 AC: 27AN: 1460834Hom.: 1 Cov.: 32 AF XY: 0.0000220 AC XY: 16AN XY: 726736
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
27
AN:
1460834
Hom.:
Cov.:
32
AF XY:
AC XY:
16
AN XY:
726736
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151870Hom.: 0 Cov.: 20 AF XY: 0.0000270 AC XY: 2AN XY: 74202
GnomAD4 genome
AF:
AC:
5
AN:
151870
Hom.:
Cov.:
20
AF XY:
AC XY:
2
AN XY:
74202
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1Uncertain:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Mar 12, 2024 | PM1, PS4 - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 16, 2021 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Identified previously in conjunction with a fusion event involving TNXB and TNXA in individuals with a phenotype of congenital adrenal hyperplasia and hypermobile Ehlers-Danlos syndrome (Morissette et al., 2015; Demirdas et al., 2017); This variant is associated with the following publications: (PMID: 26075496, 31141158, 32572181, 31229653, 27582382) - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2024 | TNXB: PP3 - |
Ehlers-Danlos syndrome due to tenascin-X deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Pediatric Services, National Institutes of Health, Clinical Center | Jan 01, 2015 | - - |
TNXB-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 14, 2024 | The TNXB c.12174C>G variant is predicted to result in the amino acid substitution p.Cys4058Trp. This variant is reported in 0.0055% of alleles in individuals of European descent in gnomAD, however this variant falls within a highly paralogous region and allele frequency data should be interpreted with caution. Likely originated from the pseudogene TNXA, this variant has been reported in TNXB exon 40 by itself or with the pseudogene-derived 120bp deletion spanning exon 35/intron 35 due to a rearrangement event (unequal crossover or gene conversion). Located closer to the CYP21A2 gene (which is in tandem 3ā to 3ā with TNXB) in the RCCX locus, this variant alone (i.e. not with the 120bp deletion) can represent a different chimera TNXA/TNXB gene (Morissette et al. 2015. PubMed ID: 26075496; Chen et al. 2016. PubMed ID: 27297501; Miller and Merke. 2018. PubMed ID: 29734195). These studies suggest that this variant could be pathogenic. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;.;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T;T;T;T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D;D
MetaSVM
Uncertain
D
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;.;D;D;.
REVEL
Uncertain
Sift
Pathogenic
.;.;D;D;.
Sift4G
Pathogenic
.;.;D;D;D
Vest4
0.82, 0.88
MVP
0.46
MPC
1.3
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at